Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1213 ARTÍCULOS , VIENDO DEL 631 AL 645

[Vitamin D and Alzheimer's disease: from an intriguing idea to a therapeutic option]

Annweiler C.

Biol Aujourdhui. 2014;208(1):89-95. doi: 10.1051/jbio/2014005. Epub 2014 Jun 23.

Classification and localization of early-stage Alzheimer's disease in magnetic resonance images using a patch-based classifier ensemble

Simões R, van Cappellen van Walsum AM, Slump CH.

Neuroradiology. 2014 Sep;56(9):709-21. doi: 10.1007/s00234-014-1385-4. Epub 2014 Jun 20.

Different patterns of brain activation in normal aging and Alzheimer's disease from cognitional sight: meta analysis using activation likelihood estimation

Sadigh-Eteghad S, Majdi A, Farhoudi M, Talebi M, Mahmoudi J.

J Neurol Sci. 2014 Aug 15;343(1-2):159-66. doi: 10.1016/j.jns.2014.05.066. Epub 2014 Jun 6.

Semiological differences between late-life schizophrenia and senile dementia

Song MH, Hamada H, Mimura M.

Keio J Med. 2014;63(2):34-8. doi: 10.2302/kjm.2012-0009-oa. Epub 2014 Jun 10.

Evaluation of selective positron emission tomography template method for spatial normalization of amyloid imaging with 11C-Pittsburgh Compound B

Chae SY, Kim HO, Oh M, Lee DY, Jin S, Oh SJ, Lee JH, Na DL, Seo SW, Lee CS, Kim JS.

J Comput Assist Tomogr. 2014 Nov-Dec;38(6):924-9. doi: 10.1097/RCT.0000000000000123.

Cholinesterase inhibitors and add-on nutritional supplements in Alzheimer's disease: a systematic review of randomized controlled trials

Rijpma A, Meulenbroek O, Olde Rikkert MG.

Ageing Res Rev. 2014 Jul;16:105-12. doi: 10.1016/j.arr.2014.06.002. Epub 2014 Jun 27.

Do patients with young onset Alzheimer's disease deteriorate faster than those with late onset Alzheimer's disease? A review of the literature

Stanley K, Walker Z.

Int Psychogeriatr. 2014 Dec;26(12):1945-53. doi: 10.1017/S1041610214001173. Epub 2014 Jul 3.

Alzheimer's disease genetics: from the bench to the clinic

Karch CM, Cruchaga C, Goate AM.

Neuron. 2014 Jul 2;83(1):11-26. doi: 10.1016/j.neuron.2014.05.041.

How proteomic ApoE serotyping could impact Alzheimer's disease risk assessment: genetic testing by proteomics

Nishimura M, Satoh M, Matsushita K, Nomura F.

Expert Rev Proteomics. 2014 Aug;11(4):405-7. doi: 10.1586/14789450.2014.936390. Epub 2014 Jul 4.

Olfactory markers of depression and Alzheimer's disease

Marine N, Boriana A.

Neurosci Biobehav Rev. 2014 Sep;45:262-70. doi: 10.1016/j.neubiorev.2014.06.016. Epub 2014 Jul 6.

Is preventive suicide a rational response to a presymptomatic diagnosis of dementia?

Powell R.

J Med Ethics. 2014 Aug;40(8):511-2. doi: 10.1136/medethics-2014-102334.

The merits and problems of Neuropsychiatric Inventory as an assessment tool in people with dementia and other neurological disorders

Lai CK.

Clin Interv Aging. 2014 Jul 8;9:1051-61. doi: 10.2147/CIA.S63504. eCollection 2014.

New targets for the development of PET tracers for imaging neurodegeneration in Alzheimer disease

Mach RH.

J Nucl Med. 2014 Aug;55(8):1221-4. doi: 10.2967/jnumed.114.127811. Epub 2014 Jul 17.

Nanotechnology and Alzheimer's disease: what has been done and what to do

Ruozi B, Belletti D, Pederzoli F, Veratti P, Forni F, Vandelli MA, Tosi G.

Curr Med Chem. 2014;21(36):4169-85. doi: 10.2174/0929867321666140716100056.

The value of biomarker comparisons between autosomal dominant and late-onset Alzheimer disease

Fleisher AS.

JAMA Neurol. 2014 Sep;71(9):1087-8. doi: 10.1001/jamaneurol.2014.1747.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias